Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)

NCT06563323 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
17
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Oregon Health and Science University

Collaborators